Pharma Times

SEPTEMBER 9, 2020

The drug's cost-effectiveness estimate when used in the maintenance setting is uncertain, the Institute has concluded

137

137

pharmaphorum

SEPTEMBER 10, 2020

Two UK biotechs – Destiny Pharma and Sporegen – have joined forces to develop a nasal spray that they say could serve as a first line of defense against coronavirus infections. The nasal spray could provide protection from infection within a few days of administration, and would be easy to make in bulk at a low cost, say the partners. The programme is still in the early stages of development, but if it works in trials would provide another approach to prevent transmission of SARS-CoV-2, the viru

Vaccines 133

Vaccines Adverse Reactions Immunity Immunization 133

Outsourcing Pharma

SEPTEMBER 8, 2020

The company has submitted an investigational new drug application for FSD201, a possible therapy for patients with severe cases of the virus.

117

117

NY Times

SEPTEMBER 8, 2020

The company halted late-stage trials of its coronavirus vaccine because of a serious suspected adverse reaction in a participant.

Adverse Reactions 98

Adverse Reactions Vaccines 98

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Pharma Times

SEPTEMBER 7, 2020

The personalised cancer treatment has received conditional approval in the US

124

124

Outsourcing Pharma

SEPTEMBER 8, 2020

The collaboration combines two solutions to help pharma and healthcare providers deal with myriad challenges associated with limited drug supplies.

107

107

NY Times

SEPTEMBER 7, 2020

The problem occurs when drug-induced side effects are viewed as a new ailment and treated with yet another drug that can cause still other side effects.

85

85

Pharma Times

SEPTEMBER 9, 2020

The funds will be used to improve single-cell RNA sequencing

120

120

pharmaphorum

SEPTEMBER 11, 2020

Brent Saunders has been out of the limelight for a few months since departing Allergan after its takeover by AbbVie, but now he is back in a leading role at Vesper Healthcare Acquisition, set up to acquire assets in the healthcare sector. Delaware-incorporated Vesper has filed a with a $400 million initial public offering (IPO) and plans to list on the Nasdaq under the symbol VSRU, with Goldman Sachs and JP Morgan acting as bookrunners.

119

119

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Outsourcing Pharma

SEPTEMBER 10, 2020

The company is delving into clinical research partnerships geared toward saving the lives of soldiers, eventually translating findings to civilian care.

91

91

NY Times

SEPTEMBER 5, 2020

An experimental medication that increases height in children with the most common form of dwarfism has raised hope that it can help them lead easier lives. But some say the condition is not a problem in need of a cure.

83

83

Pharma Times

SEPTEMBER 7, 2020

Development of SPOR-COV is supported by a grant from Innovate UK

113

113

pharmaphorum

SEPTEMBER 10, 2020

September is Global Diversity and Inclusion month – David Peacock, managing director of MSD in the UK shares with us his insights on why diversity and inclusion is so important and why it is critical to the future success of the life sciences sector. Taking diversity and inclusion seriously, supported by robust policies and accountability for implementation, creates success for everyone, fostering happy, healthy and invested employees, new ways of thinking and opportunities for growth, learning

109

109

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Eye on FDA

SEPTEMBER 10, 2020

Vaccines for COVID-19 are the focus of the moment – politically and scientifically speaking. On the political front, there has not only been jockeying to try to squeeze the square peg of a vaccine development timeline into a round hole of political convenience, there is also skepticism expressed by a wary public that the process has become politicized – an unfortunate impression to be sure.

Communication 82

Communication Vaccines Immunity Immunization 82

Outsourcing Pharma

SEPTEMBER 9, 2020

The clinical-stage biotech firm is investigating early efficacy of its Cymerus mesenchymal stem cells for treatment of severe COVID-19 patients.

68

68

Pharma Times

SEPTEMBER 9, 2020

The move follows a report which found it is not clear that the current programme will be able to drive the progress needed in the timescale available

112

112

pharmaphorum

SEPTEMBER 7, 2020

A trial of Russia’s Sputnik V coronavirus vaccine has shown the jab produces an immune response, although the study was too small to produce conclusive findings, particularly on safety. Preliminary results published in The Lancet are from a non-randomised phase 1/2 trial of 76 people aged 18-60, which found an antibody response within 21 days and no serious adverse events after 42 days.

Immunity 107

Immunity Immunization Vaccines Hospitals 107

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

NY Times

SEPTEMBER 11, 2020

Los ensayos clínicos de varios tratamientos experimentales muestran nuevos avances y la posibilidad de que la parálisis del trastorno pueda ser frenada.

60

60

Outsourcing Pharma

SEPTEMBER 9, 2020

The Inspire Research Accelerator is designed to let academic researchers anywhere in the world to collaborate with the company.

53

53

Pharma Times

SEPTEMBER 7, 2020

Inhaled ensifentrine will be assessed in hospitalised patients

110

110

pharmaphorum

SEPTEMBER 9, 2020

Geneticist Dr Charles Steward has spent his career studying the human genome – but his work became much more personal when his children were diagnosed with severe neurological diseases. Charlie told pharmaphorum how his search for a genetic cause has led him to straddle the divide between scientist and patient advocate. For some people, a job is more than just a job.

Hospitals 99

Hospitals 99

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

NY Times

SEPTEMBER 10, 2020

A group of career scientists at the Food and Drug Administration vowed that their work would continue unimpeded and independent of political influence.

Vaccines 60

Vaccines 60

Drug Patent Watch

SEPTEMBER 11, 2020

Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-nine…. The post Patent delisted for Astrazeneca Ab drug BYDUREON PEN appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Times

SEPTEMBER 8, 2020

The decisions bring a raft of new treatment options for conditions including epilepsy, depression and cancer

109

109

pharmaphorum

SEPTEMBER 8, 2020

Sandoz’s Pierre Bourdage looks at the unexpected secondary impacts of COVID-19 on countries and healthcare systems, and asks how pharma can help improve sustainability to tackle them. It is undeniable that the COVID-19 pandemic has had a tremendous impact on all aspects of our lives, with ripple effects continuing to evolve. Faced with constant and overwhelming information about the pandemic, including rapidly changing policy responses, there is also an alarming acceleration of a healthcare sust

Biosimilars 98

Biosimilars Drug Pricing Chemotherapy Vaccines 98

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.